![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CARMN |
Gene summary for CARMN |
![]() |
Gene information | Species | Human | Gene symbol | CARMN | Gene ID | 728264 |
Gene name | cardiac mesoderm enhancer-associated non-coding RNA | |
Gene Alias | CARMEN | |
Cytomap | 5q32 | |
Gene Type | ncRNA | GO ID | GO:0008150 | UniProtAcc | NA |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
728264 | CARMN | EOLP-1 | Human | Oral cavity | EOLP | 3.58e-17 | 5.85e-01 | -0.0202 |
728264 | CARMN | EOLP-2 | Human | Oral cavity | EOLP | 3.02e-04 | 2.99e-01 | -0.0203 |
728264 | CARMN | NEOLP-1 | Human | Oral cavity | NEOLP | 1.42e-03 | 2.77e-01 | -0.0194 |
728264 | CARMN | NEOLP-2 | Human | Oral cavity | NEOLP | 3.63e-23 | 5.59e-01 | -0.0196 |
728264 | CARMN | NEOLP-3 | Human | Oral cavity | NEOLP | 1.85e-16 | 5.17e-01 | -0.0191 |
728264 | CARMN | ATC12 | Human | Thyroid | ATC | 1.21e-04 | 1.79e-01 | 0.34 |
728264 | CARMN | ATC13 | Human | Thyroid | ATC | 4.25e-14 | 2.57e-01 | 0.34 |
728264 | CARMN | ATC2 | Human | Thyroid | ATC | 3.71e-05 | 6.58e-01 | 0.34 |
728264 | CARMN | ATC4 | Human | Thyroid | ATC | 5.74e-08 | 2.33e-01 | 0.34 |
728264 | CARMN | ATC5 | Human | Thyroid | ATC | 2.12e-13 | 2.95e-01 | 0.34 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |